← Leaderboards
Lewis Kaufman
Icahn School Of Medicine At Mount Sinai
$8,156,411
Attributed
$8,156,411
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,156,411 · 5
By mechanism
R01$7,512,136 · 4
K08$644,275 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Kristin Meliambro$2,184,634
- Detlef Olaf Schlondorff$1,515,842
- Kirk N Campbell$10,746,650
- Ilse Sofia Daehn$7,432,625
Others in their field
Top investigators on “Mouse Model”
- Dennis R. Burton · Scripps Research Institute$280,661,242
- David Heimbrook · Leidos Biomedical Research, Inc.$84,491,283
- Kc Kent Lloyd · University Of California At Davis$74,285,556
- Alan F Horwitz · University Of Virginia Charlottesville$73,668,592
- Stanley B Prusiner · University Of California San Francisco$61,905,394
- Ed Lein · Allen Institute$59,425,748
Research focus
Mouse ModelPodocytePredispositionPhenotypeTransgenic MiceRenal Glomerular DiseaseMediatingInjuryKidney DiseasesKidneyNephrotic SyndromeOverexpressionGenesPlayTransgenic OrganismsPathogenesisGeneticKnockout MiceSignal TransductionBindingProteinuriaFocal Segmental GlomerulosclerosisResistanceReporting
Grant awards (24)
Podocyte-specific Rap1 agonism for treatment of glomerular disease$618,264
R01 · FY2025 · DK · contact PI
Podocyte-specific Rap1 agonism for treatment of glomerular disease$593,532
R01 · FY2024 · DK · contact PI
DACH1 transcriptomic regulation of glucocorticoid-responsive glomerular disease$357,984
R01 · FY2024 · DK · contact PI
Podocyte-specific Rap1 agonism for treatment of glomerular disease$618,264
R01 · FY2023 · DK · contact PI
DACH1 transcriptomic regulation of glucocorticoid-responsive glomerular disease$372,900
R01 · FY2023 · DK · contact PI
Podocyte-specific Rap1 agonism for treatment of glomerular disease$652,616
R01 · FY2022 · DK · contact PI
DACH1 transcriptomic regulation of glucocorticoid-responsive glomerular disease$372,900
R01 · FY2022 · DK · contact PI
DACH1 transcriptomic regulation of glucocorticoid-responsive glomerular disease$372,900
R01 · FY2021 · DK · contact PI
DACH1 transcriptomic regulation of glucocorticoid-responsive glomerular disease$372,900
R01 · FY2020 · DK · contact PI
Podocyte to podocyte propagation of hypertrophic signals$381,375
R01 · FY2019 · DK · contact PI
Podocyte to podocyte propagation of hypertrophic signals$381,375
R01 · FY2018 · DK · contact PI
Podocyte to podocyte propagation of hypertrophic signals$381,375
R01 · FY2017 · DK · contact PI
Podocyte to podocyte propagation of hypertrophic signals$381,375
R01 · FY2016 · DK · contact PI
Sidekick-1 Upregulation in Podocytes Induces FSGS by Disrupting MAGI-1 Function$320,625
R01 · FY2013 · DK · contact PI
Sidekick-1 Upregulation in Podocytes Induces FSGS by Disrupting MAGI-1 Function$332,254
R01 · FY2012 · DK · contact PI
Sidekick-1 Upregulation in Podocytes Induces FSGS by Disrupting MAGI-1 Function$332,254
R01 · FY2011 · DK · contact PI
Sidekick-1 Upregulation in Podocytes Induces FSGS by Disrupting MAGI-1 Function$335,610
R01 · FY2010 · DK · contact PI
Sidekick-1 Upregulation in Podocytes Induces FSGS by Disrupting MAGI-1 Function$333,633
R01 · FY2009 · DK · contact PI
Sidekick proteins in HIV-associated nephropathy$128,655
K08 · FY2009 · DK · contact PI
Sidekick proteins in HIV-associated nephropathy$128,655
K08 · FY2008 · DK · contact PI
Sidekick proteins in HIV-associated nephropathy$1,000
K08 · FY2008 · DK · contact PI
Sidekick proteins in HIV-associated nephropathy$128,655
K08 · FY2007 · DK · contact PI
Sidekick proteins in HIV-associated nephropathy$128,655
K08 · FY2006 · DK · contact PI
Sidekick proteins in HIV-associated nephropathy$128,655
K08 · FY2005 · DK